Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China.
Pulin LiLing HuangRui HanMin TangGuanghe FeiDaxiong ZengRan Wang
Published in: Expert review of anti-infective therapy (2024)
Amid the Omicron outbreak, Paxlovid has proven to be a safe and effective treatment for reducing hospitalization durations for patients with mild to moderate COVID-19.